FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Heritage Pharmaceuticals Colistimethate for Injection Recall

Colistimethate for Injection USP, 150 mg per vial, Rx Only, Manufactured by: Emcure Ph…

Heritage Pharmaceuticals, Inc. · Eatontown, NJ

Risk level
Class II
Reported by FDA
Mar 25, 2015
Recall ID
D-0415-2015
Check your lot numberHow we source this data

Summary

Heritage Pharmaceuticals recalled Colistimethate for Injection starting Feb 25, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0415-2015 on Mar 25, 2015. Reason: Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

Product description

Colistimethate for Injection USP, 150 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc. NDC 23155-193-31

Lot numbers, UPCs & expiration codes

Lot # VCOA002; Exp. 09/14, VCOA003; Exp. 10/14, VCOA004; Exp. 10/14 VCOA005; Exp. 01/15, VCOA006; Exp 03/15, VCOA007; Exp 09/15, VCOA008; Exp. 12/15, VCOA009; Exp. 02/16, VCOA010; Exp. 10/16 VCOA011; Exp. 10/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0415-2015
Classification
Class II
Status
Terminated
Recall initiated
Feb 25, 2015
FDA report date
Mar 25, 2015
Recall type
Voluntary: Firm initiated
Recalling firm
Heritage Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0415-2015, exactly as published.

Show all FDA fields
City
Eatontown
State
NJ
Status
Terminated
Country
United States
Event ID
70592
Address
12 Christopher Way
Address (line 2)
Suite 300
Code information
Lot # VCOA002; Exp. 09/14, VCOA003; Exp. 10/14, VCOA004; Exp. 10/14 VCOA005; Exp. 01/15, VCOA006; Exp 03/15, VCOA007; Exp 09/15, VCOA008; Exp. 12/15, VCOA009; Exp. 02/16, VCOA010; Exp. 10/16 VCOA011; Exp. 10/16
Postal code
07724-3330
Report date
Mar 25, 2015
Product type
Drugs
Recall number
D-0415-2015
Classification
Class II
Recalling firm
Heritage Pharmaceuticals, Inc.
Termination date
Feb 26, 2016
Reason for recall
Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Colistimethate for Injection USP, 150 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc. NDC 23155-193-31
Distribution pattern
Nationwide
Recall initiation date
Feb 25, 2015
Initial firm notification
Press Release
Center classification date
Mar 17, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0415-2015, published Mar 25, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls